Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.
The collaboration deal aims to develop a scalable and practical delivery and health care provider training model for Compass’ COMP360 psilocybin therapy for treatment-resistant depression, pending regulatory approval, according to a news release Monday.
Compass said that the first phase of the collaboration will involve an in-depth information exchange on the COMP360 psilocybin treatment delivery model. The two companies will work together to gain insights into the patient care experience, depression patient pathways, and care reimbursement processes.
The two companies will also explore more innovative care pathways for TRD patients and conduct research into therapist training, support, and education.
Journey Clinical brings to the table a network of more than 2,000 therapists, an in-house model of therapist peer support and mentorship, and partnerships with leading therapist training providers. The company has built an infrastructure to support broad access to new psychedelic treatments for mental health conditions.
“This collaboration with Compass is closely aligned with Journey Clinical’s aim to support the millions of people in the U.S. living with mental illness to access psychedelic treatments safely and effectively,” Journey Clinical CEO Jonathan Sabbagh said in a statement.
“Compass is forming a comprehensive and diverse network of research collaborations to inform how COMP360 psilocybin treatment can be best integrated into the U.S. health system,” said Kabir Nath, CEO of Compass Pathways. Previous collaborations include agreements with Greenbrook TMS and Hackensack Meridian Health.
Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.
Your email address will not be published. Required fields are marked *
Unpack the industry with the daily cannabis newsletter for business leaders.
Sign up
Unpack the industry with the daily cannabis newsletter for business leaders.
Sign up
The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis
Crain Communications Inc © 2017 – . All rights reserved.
Crain Communications Inc © 2017 – . All rights reserved.
Unpack the industry with the daily cannabis newsletter for business leaders.